[{"address1": "3710 \u2013 33rd Street NW", "city": "Calgary", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403 455 7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 64, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 391655, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Scott Bumby D.V.M., M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 6515, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 74, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 110445, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 50, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 157500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 54, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 61, "title": "Consultant of Clinical Operations", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.585, "open": 0.582, "dayLow": 0.531, "dayHigh": 0.5957, "regularMarketPreviousClose": 0.585, "regularMarketOpen": 0.582, "regularMarketDayLow": 0.531, "regularMarketDayHigh": 0.5957, "payoutRatio": 0.0, "beta": -0.088, "forwardPE": -0.33419162, "volume": 55224, "regularMarketVolume": 55224, "averageVolume": 1946103, "averageVolume10days": 271460, "averageDailyVolume10Day": 271460, "bid": 0.5448, "ask": 0.5841, "bidSize": 2, "askSize": 2, "marketCap": 3228434, "fiftyTwoWeekLow": 0.531, "fiftyTwoWeekHigh": 1.79, "allTimeHigh": 495.72, "allTimeLow": 0.531, "fiftyDayAverage": 0.79072, "twoHundredDayAverage": 0.88373, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1925934, "profitMargins": 0.0, "floatShares": 4573513, "sharesOutstanding": 5784688, "sharesShort": 7330, "sharesShortPriorMonth": 19700, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.13485, "heldPercentInstitutions": 0.046430003, "shortRatio": 0.14, "shortPercentOfFloat": 0.0015, "impliedSharesOutstanding": 6207996, "bookValue": 0.536, "priceToBook": 1.0412313, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -1880849, "trailingEps": -0.46, "forwardEps": -1.67, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -0.754, "52WeekChange": -0.60142857, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 0.5581, "targetHighPrice": 13.711113, "targetLowPrice": 13.711113, "targetMeanPrice": 13.711113, "targetMedianPrice": 13.711113, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1063477, "totalCashPerShare": 0.204, "ebitda": -2552788, "totalDebt": 80473, "quickRatio": 1.51, "currentRatio": 1.777, "debtToEquity": 3.963, "returnOnAssets": -0.42154998, "returnOnEquity": -0.79440004, "freeCashflow": -2797770, "operatingCashflow": -3075508, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "XRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "regularMarketChangePercent": -4.5982895, "regularMarketPrice": 0.5581, "messageBoardId": "finmb_259860883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "exchange": "NCM", "corporateActions": [], "postMarketTime": 1762559073, "regularMarketTime": 1762549200, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1632403800000, "postMarketChangePercent": -1.6663669, "earningsTimestamp": 1755057600, "earningsTimestampStart": 1763040600, "earningsTimestampEnd": 1763040600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.46, "epsForward": -1.67, "epsCurrentYear": -1.307, "priceEpsCurrentYear": -0.4270084, "fiftyDayAverageChange": -0.23262, "fiftyDayAverageChangePercent": -0.29418758, "twoHundredDayAverageChange": -0.32563, "twoHundredDayAverageChangePercent": -0.36847228, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "cryptoTradeable": false, "postMarketPrice": 0.5488, "postMarketChange": -0.0092999935, "regularMarketChange": -0.026899993, "regularMarketDayRange": "0.531 - 0.5957", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1946103, "fiftyTwoWeekLowChange": 0.027099967, "fiftyTwoWeekLowChangePercent": 0.051035717, "fiftyTwoWeekRange": "0.531 - 1.79", "fiftyTwoWeekHighChange": -1.2319, "fiftyTwoWeekHighChangePercent": -0.6882123, "fiftyTwoWeekChangePercent": -60.142857, "displayName": "XORTX Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]